Raymond James & Associates Sells 65,726 Shares of Healthpeak Properties, Inc. (NYSE:DOC)

Raymond James & Associates reduced its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 19.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 279,331 shares of the real estate investment trust's stock after selling 65,726 shares during the period. Raymond James & Associates owned about 0.12% of Healthpeak Properties worth $3,718,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in DOC. Orion Portfolio Solutions LLC raised its stake in shares of Healthpeak Properties by 31.6% in the third quarter. Orion Portfolio Solutions LLC now owns 386,844 shares of the real estate investment trust's stock worth $4,716,000 after acquiring an additional 92,966 shares during the last quarter. GSA Capital Partners LLP bought a new stake in Healthpeak Properties during the third quarter worth $741,000. Employees Retirement System of Texas raised its position in Healthpeak Properties by 39.5% during the third quarter. Employees Retirement System of Texas now owns 212,000 shares of the real estate investment trust's stock worth $2,584,000 after acquiring an additional 60,000 shares in the last quarter. American Century Companies Inc. raised its position in Healthpeak Properties by 2.0% during the third quarter. American Century Companies Inc. now owns 3,364,875 shares of the real estate investment trust's stock worth $41,018,000 after acquiring an additional 65,814 shares in the last quarter. Finally, Victory Capital Management Inc. raised its position in Healthpeak Properties by 9.9% during the third quarter. Victory Capital Management Inc. now owns 2,183,206 shares of the real estate investment trust's stock worth $26,613,000 after acquiring an additional 196,861 shares in the last quarter. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Healthpeak Properties Price Performance

Shares of NYSE DOC traded down $0.16 during midday trading on Friday, hitting $18.52. 5,878,646 shares of the company's stock were exchanged, compared to its average volume of 5,989,111. Healthpeak Properties, Inc. has a 12-month low of $15.24 and a 12-month high of $22.38. The company has a current ratio of 0.67, a quick ratio of 0.67 and a debt-to-equity ratio of 1.00. The company has a market cap of $13.14 billion, a price-to-earnings ratio of 33.07, a PEG ratio of 1.84 and a beta of 1.02. The business's fifty day moving average price is $15.35 and its two-hundred day moving average price is $13.30.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Wells Fargo & Company assumed coverage on shares of Healthpeak Properties in a research note on Monday, March 25th. They issued an "equal weight" rating and a $19.00 price target on the stock. Truist Financial cut their price objective on shares of Healthpeak Properties from $15.00 to $14.00 and set a "hold" rating on the stock in a report on Friday, December 22nd. StockNews.com upgraded Healthpeak Properties from a "sell" rating to a "hold" rating in a research note on Friday, April 5th. Royal Bank of Canada lifted their target price on Healthpeak Properties from $21.00 to $22.00 and gave the stock an "outperform" rating in a research note on Wednesday. Finally, Compass Point lowered their price objective on Healthpeak Properties from $19.00 to $18.00 and set a "buy" rating on the stock in a research note on Tuesday, January 2nd. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $17.67.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.